MISC last minute cards for boards Flashcards

1
Q

MC primary cardiac tumor and where does it classical arise.

They secrete what vasoactive substance which may lead to const. sx

A

Myxoma

IL-6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

second mc primary cardiac tumor and

third mc

A

lipoma

paplillary fibroelastoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where do myxoma’s generally arise

A

fossa ovalis in the left atrium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Associated syndrome with myxoma (<5%)

A

Carney complex = myxoma + pigmented skin lesions adnd endocrine overactivity. It is AD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

reoccurance after myxoma removed surgically

A

5-10% need semi annual screening until first 4 years out when this risk decreases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

dumbell appearance of intra-atrial seputm

A

lipomatous hypertrophy (on both sides of the fossa ovals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

cardiac tumor that is common with tuberous sclerosis

A

Rhabdomyoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rhabdomyoma is commonly associated with this genetic condition

A

tuberous sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MC primary malignant tumor of the heart

  1. what is their most common location
A

sarcoma, the most frequently seen are angiosarcoma

  1. left atrium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. 2 MC primary malignant tumors

2. MC metastitic tumors (6)

A
  1. sarcomas and lymphomas

2. lung, melanoma, breast, renal, esophagus lymphoma/leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

3 secondary causes of hyperlipidemia

A
  1. nephrotic syndrome
  2. drugs esp cyclosporine
  3. hypothyroid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

4 clinical ASCVD risk groups and statin strength for its 40-75

A
  1. DM - mod (high if ASCVD > 7.5)
  2. CAD/PAD -high
  3. ASCVD risk > 7.5% mod (high)
  4. FH ldl > 190 or > 160 on treatment -high
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How define high vs. mod intensity statin and what are they

A

> 50% reduction in LDL is high intensity.
30 < 50% is mod.

High Lipitor 80 or rosuva 40
Mod atorva 10 or 20 rousva 5 or 10, silva 20-40, prove 40-80, pitta 2-4, lova 40, fluva XL 80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When can use a mod dose statin

A

ASVD risk > 7.5 or DM without elevated ASCVD risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

when use lower intensity statin

A

in general wouldn’t use them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NNT for high vs. low intensity stat

A

ARR 2.2% 1/.002 = 1 in 40

17
Q

NNH for causing DM

A

100.

18
Q

limit for intermediate ASCVD risk calc for statin

A

5-7.5% IIa to add a statin

19
Q

what groups have the ascvd lower risk than calculator

A

Older with lower comorbidities, East Asian , high SES, hispanics

20
Q

What additional risk features can get you on a statin if your other things don’t

A
  1. ASCVD RISK 5-7.5
  2. LDL > 160
  3. HS CRP > 2
  4. CAC > 300
  5. ABI > 0.9
21
Q

Underestimated risk of ASCVD

A

s. asian
HIV
systemic inflammatory

22
Q

mod elevated TAG do we need to do anything (ie 220)

A

Do nothing or increase statin dose to full dose.

23
Q

ACCORD with fenofibrate +statin

A

did nothing

24
Q

Major negative fenofibrate troial

A

accord. fibrates didn’t change mort

25
Q

Niacin not only didnt improve mortality with its improved HDL it led to these SE

A

increased dm (which was likely the problem), infection and bleeding

26
Q

double statin rule

A

rule of 6’s, 6% reduction

27
Q

Zetia imporevit

A

ACS pts lowered compiste

lowers cholesterol by 20%

28
Q

pcsk9 are approved for which patients

A

Those with clinical ASCVD or FH

29
Q

consensus statement from ACC when can you use a second lipid lowering med

A

when in one of the 4 risk groups ASCVD, DM, ASCVD risk > 7.5%, or FHish with LDL of >=190 and lipids not at goal (>70) or didn’t get a 50% reduction

30
Q

can’t use ascvd risk calc for 10 yr risk until

A

40

31
Q

3 genes for FH

A

LDL-R, apoB, PCSK9

32
Q

LDL for herterozygous and homozygous FH

A

hetero 190-400 (1:250), homo > 400 (1:400)

33
Q

definite dx of FH on PE

A

tendinous xanthoma

34
Q

when niacin, omega 3, or fibrates use based on current gl

A

only in extreme hyper tag based on current guidelines